93 related articles for article (PubMed ID: 8766873)
1. Histopathology of the substantia nigra in Alzheimer's disease.
Reyes MG; Faraldi F; Chandran R; Verano A; Levi AC
Panminerva Med; 1996 Mar; 38(1):8-14. PubMed ID: 8766873
[TBL] [Abstract][Full Text] [Related]
2. Decreased nigral neuromelanin in Alzheimer's disease.
Reyes MG; Faraldi F; Rydman R; Wang CC
Neurol Res; 2003 Mar; 25(2):179-82. PubMed ID: 12635519
[TBL] [Abstract][Full Text] [Related]
3. Pathological correlates of extrapyramidal signs in Alzheimer's disease.
Liu Y; Stern Y; Chun MR; Jacobs DM; Yau P; Goldman JE
Ann Neurol; 1997 Mar; 41(3):368-74. PubMed ID: 9066358
[TBL] [Abstract][Full Text] [Related]
4. Cortical Lewy bodies in Alzheimer's disease.
Kazee AM; Han LY
Arch Pathol Lab Med; 1995 May; 119(5):448-53. PubMed ID: 7748074
[TBL] [Abstract][Full Text] [Related]
5. The aging substantia nigra: quantitative histologic study.
Faraldi F; Reyes MG; Alfieri E; Levi AC
Panminerva Med; 1994 Sep; 36(3):103-8. PubMed ID: 7877822
[TBL] [Abstract][Full Text] [Related]
6. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.
Hardman CD; Halliday GM; McRitchie DA; Cartwright HR; Morris JG
Exp Neurol; 1997 Mar; 144(1):183-92. PubMed ID: 9126169
[TBL] [Abstract][Full Text] [Related]
7. Distribution of basal ganglia lesions in diffuse neurofibrillary tangles with calcification: a clinicopathological study of five autopsy cases.
Tsuchiya K; Nakayama H; Iritani S; Arai T; Niizato K; Haga C; Matsushita M; Ikeda K
Acta Neuropathol; 2002 Jun; 103(6):555-64. PubMed ID: 12012087
[TBL] [Abstract][Full Text] [Related]
8. The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs.
Burns JM; Galvin JE; Roe CM; Morris JC; McKeel DW
Neurology; 2005 Apr; 64(8):1397-403. PubMed ID: 15851730
[TBL] [Abstract][Full Text] [Related]
9. Lewy bodies in Alzheimer disease--one or two diseases?
Bergeron C; Pollanen M
Alzheimer Dis Assoc Disord; 1989; 3(4):197-204. PubMed ID: 2557056
[TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
11. No correlation between nigral degeneration and striatal plaques in Alzheimer's disease.
Love S; Wilcock GK; Matthews SM
Acta Neuropathol; 1996; 91(4):432-6. PubMed ID: 8928622
[TBL] [Abstract][Full Text] [Related]
12. [An autopsy case of amyotrophic lateral sclerosis with concomitant Alzheimer's and incidental Lewy body diseases].
Su M; Wakabayashi K; Tanno Y; Inuzuka T; Takahashi H
No To Shinkei; 1996 Oct; 48(10):931-6. PubMed ID: 8921532
[TBL] [Abstract][Full Text] [Related]
13. Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra.
Greffard S; Verny M; Bonnet AM; Beinis JY; Gallinari C; Meaume S; Piette F; Hauw JJ; Duyckaerts C
Arch Neurol; 2006 Apr; 63(4):584-8. PubMed ID: 16606773
[TBL] [Abstract][Full Text] [Related]
14. Neuronal loss in the substantia nigra in patients with Alzheimer's disease and Parkinson's disease in relation to extrapyramidal symptoms and dementia.
Rinne JO; Rummukainen J; Paljärvi L; Säkö E; Mölsä P; Rinne UK
Prog Clin Biol Res; 1989; 317():325-32. PubMed ID: 2602422
[TBL] [Abstract][Full Text] [Related]
15. Relevance of COX-2 gene expression in dementia with lewy bodies associated with Alzheimer pathology.
Saldaña M; Pujols L; ; Roca-Ferrer J; Cardozo A; Aguilar E; Bonastre M; Marin C
Mov Disord; 2008 Apr; 23(6):804-10. PubMed ID: 18307244
[TBL] [Abstract][Full Text] [Related]
16. Sex differences for clinical correlates of substantia nigra neuron loss in people with Lewy body pathology.
Bayram E; Coughlin DG; Rajmohan R; Litvan I
Biol Sex Differ; 2024 Jan; 15(1):8. PubMed ID: 38243325
[TBL] [Abstract][Full Text] [Related]
17. The pedunculopontine nucleus in Parkinson's disease.
Zweig RM; Jankel WR; Hedreen JC; Mayeux R; Price DL
Ann Neurol; 1989 Jul; 26(1):41-6. PubMed ID: 2549845
[TBL] [Abstract][Full Text] [Related]
18. A pathological study of the association between Lewy body disease and Alzheimer's disease.
Gibb WR; Mountjoy CQ; Mann DM; Lees AJ
J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):701-8. PubMed ID: 2545826
[TBL] [Abstract][Full Text] [Related]
19. The substantia nigra and ventral tegmental area in Alzheimer's disease and Down's syndrome.
Gibb WR; Mountjoy CQ; Mann DM; Lees AJ
J Neurol Neurosurg Psychiatry; 1989 Feb; 52(2):193-200. PubMed ID: 2539435
[TBL] [Abstract][Full Text] [Related]
20. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.
Banati RB; Daniel SE; Blunt SB
Mov Disord; 1998 Mar; 13(2):221-7. PubMed ID: 9539333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
